|
|
|
Insider
Information: |
Thompson Tommy G |
Relationship: |
Director |
City: |
Saint Louis |
State: |
MO |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
10 |
|
Direct
Shares |
2,385,169 |
|
Indirect Shares
|
5,118,253 |
|
|
Direct
Value |
$23,352,883 |
|
|
Indirect Value
|
$15,778,516 |
|
|
Total
Shares |
7,503,422 |
|
|
Total
Value |
$39,131,400 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
5
|
3
|
Stock
price went up :
|
1
|
3
|
Stock
price went down : |
4
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
3.0
|
Percentage
Gain/Loss : |
-26.9%
|
104.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Centene Corp |
CNC |
Director |
2021-12-31 |
227,334 |
2021-12-31 |
160,896 |
Premium* |
|
CR Bard Inc |
BCR |
Director |
2017-12-29 |
0 |
2005-10-03 |
0 |
Premium* |
|
Pure Bioscience |
PURE |
Director |
2009-07-01 |
589,537 |
2007-05-23 |
0 |
Premium* |
|
United Therapeutics Corp |
UTHR |
|
2024-03-11 |
8,480 |
2024-03-08 |
14,000 |
Premium* |
|
Careview Communications Inc |
CRVW |
Director |
2012-12-26 |
1,325,222 |
2013-04-01 |
4,845,424 |
Premium* |
|
Plus Therapeutics Inc |
PSTV |
Director |
2015-05-08 |
103,986 |
2015-09-03 |
83,600 |
Premium* |
|
Therapeuticsmd Inc |
TXMD |
Director |
2022-08-18 |
5,954 |
2022-08-18 |
14,333 |
Premium* |
|
Physicians Realty Trust |
DOC |
Director |
2024-03-01 |
0 |
2024-03-01 |
0 |
Premium* |
|
Vyant Bio Ord Shs |
VYNT |
Director |
2013-10-10 |
2,500 |
2013-10-10 |
0 |
Premium* |
|
Healthpeak Properties |
PEAK |
Director |
2024-04-26 |
122,156 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
284 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 10 of 12
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
UTHR |
United Therapeutics Corp |
Director |
|
2015-09-29 |
4 |
OE |
$51.77 |
$258,850 |
D/D |
5,000 |
5,000 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2016-03-01 |
4 |
S |
$126.54 |
$379,620 |
D/D |
(3,000) |
0 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2016-03-01 |
4 |
OE |
$48.11 |
$144,330 |
D/D |
3,000 |
3,000 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2016-06-08 |
4 |
S |
$115.62 |
$231,247 |
D/D |
(2,000) |
0 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2016-06-08 |
4 |
OE |
$52.65 |
$105,300 |
D/D |
2,000 |
2,000 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2016-09-26 |
4 |
S |
$125.57 |
$162,111 |
D/D |
(1,291) |
0 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2016-09-26 |
4 |
OE |
$48.11 |
$62,110 |
D/D |
1,291 |
1,291 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2017-03-22 |
4 |
S |
$139.37 |
$278,740 |
D/D |
(2,000) |
0 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2017-03-22 |
4 |
OE |
$54.77 |
$109,540 |
D/D |
2,000 |
2,000 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2017-06-21 |
4 |
D |
$131.93 |
$85,755 |
D/D |
(650) |
1,750 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2017-06-21 |
4 |
OE |
$0.00 |
$35,601 |
D/D |
2,400 |
2,400 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2018-06-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,620 |
3,370 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2018-12-11 |
4 |
D |
$111.00 |
$99,900 |
D/D |
(900) |
3,370 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2018-12-11 |
4 |
OE |
$52.65 |
$47,385 |
D/D |
900 |
4,270 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2019-02-05 |
4 |
AS |
$117.00 |
$46,800 |
D/D |
(400) |
2,970 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2019-03-18 |
4 |
OE |
$52.65 |
$900,315 |
D/D |
17,100 |
20,070 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2019-06-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,870 |
21,940 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2020-03-02 |
4 |
S |
$103.59 |
$444,409 |
D/D |
(4,290) |
26,150 |
0 |
% |
|
UTHR |
United Therapeutics Corp |
Director |
|
2020-03-02 |
4 |
OE |
$51.77 |
$440,045 |
D/D |
8,500 |
30,440 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2020-05-05 |
4 |
S |
$112.56 |
$348,921 |
I/I |
(3,100) |
14,000 |
0 |
% |
|
UTHR |
United Therapeutics Corp |
Director |
|
2020-06-09 |
4 |
S |
$126.79 |
$533,806 |
I/I |
(4,210) |
9,790 |
0 |
% |
|
UTHR |
United Therapeutics Corp |
Director |
|
2021-03-10 |
4 |
OE |
$54.77 |
$676,410 |
D/D |
12,350 |
17,190 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2021-03-10 |
4 |
D |
$159.68 |
$1,972,048 |
D/D |
(12,350) |
4,840 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2021-06-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,680 |
6,520 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
|
|
2022-03-03 |
4 |
D |
$174.96 |
$262,440 |
D/D |
(1,500) |
6,520 |
0 |
- |
|
284 Records found
|
|
Page 10 of 12 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|